
Source: [[Generator/PDF/Unit 1 Pathoma .pdf]]

---

###### Page 1

# **Growth** **Adaptations,** **Cellular** 

# **Injury,** **and** **Cell** **Death** 

### **GROWTH** **ADAPTATIONS** I.**BASIC** **PRINCIP-ES**

### A.AO PSHBO JT JO IPNFPTUBTJT XJUI UIF QIZTJPMPHJD TUSFTT QMBDFE PO JU. 

### B.AO JODSFBTF EFDSFBTF PS DIBOHF JO TUSFTT PO BO PSHBO DBO SFTVMU JO HSPXUI

### BEBQUBUJPOT.

### I-**H:PERP-ASIA** **AND** **H:PERTROPH:** 

### A.AO JODSFBTF JO TUSFTT MFBET UP BO JODSFBTF JO PSHBO TJ[F.

### 1.0DDVST WJB BO JODSFBTF JO UIF TJ[F 	IZQFSUSPQIZ
 BOEPS UIF OVNCFS

### 	IZQFSQMBTJB
 PG DFMMT B.)ZQFSUSPQIZ JOWPMWFT HFOF BDUJWBUJPO QSPUFJO TZOUIFTJT BOE QSPEVDUJPO PG

### PSHBOFMMFT. C.)ZQFSQMBTJB JOWPMWFT UIF QSPEVDUJPO PG OFX DFMMT GSPN TUFN DFMMT. D.)ZQFSQMBTJB BOE IZQFSUSPQIZ HFOFSBMMZ PDDVS UPHFUIFS 	F.H. VUFSVT EVSJOH

### QSFHOBODZ
.

### 1.1FSNBOFOU UJTTVFT 	F.H. DBSEJBD NVTDMF TLFMFUBM NVTDMF BOE OFSWF
 IPXFWFS 

### DBOOPU NBLF OFX DFMMT BOE VOEFSHP IZQFSUSPQIZ POMZ. 2.'PS FYBNQMF DBSEJBD NZPDZUFT VOEFSHP IZQFSUSPQIZ OPU IZQFSQMBTJB JO 

### SFTQPOTF UP TZTUFNJD IZQFSUFOTJPO 	'JH. 1.1). E.1BUIPMPHJD IZQFSQMBTJB 	F.H. FOEPNFUSJBM IZQFSQMBTJB
 DBO QSPHSFTT UP EZTQMBTJB BOE

### FWFOUVBMMZ DBODFS. 

### 1.A OPUBCMF FYDFQUJPO JT CFOJHO QSPTUBUJD IZQFSQMBTJB 	B1)
 XIJDI EPFT OPU 

### JODSFBTF UIF SJTL GPS QSPTUBUF DBODFS.

### III.**ATROPH:**

### A.A EFDSFBTF JO TUSFTT 	F.H. EFDSFBTFE IPSNPOBM TUJNVMBUJPO EJTVTF PS EFDSFBTFE

### OVUSJFOUTCMPPE TVQQMZ
 MFBET UP B EFDSFBTF JO PSHBO TJ[F 	BUSPQIZ
. 

### 1.0DDVST WJB B EFDSFBTF JO UIF TJ[F BOE OVNCFS PG DFMMT B.DFDSFBTF JO DFMM OVNCFS PDDVST WJB BQPQUPTJT. C.DFDSFBTF JO DFMM TJ[F PDDVST WJB VCJRVJUJOQSPUFPTPNF EFHSBEBUJPO PG UIF

### DZUPTLFMFUPO BOE BVUPQIBHZ PG DFMMVMBS DPNQPOFOUT.

### 1.IO VCJRVJUJOQSPUFPTPNF EFHSBEBUJPO JOUFSNFEJBUF GJMBNFOUT PG UIF DZUPTLFMFUPO

### BSF UBHHFE XJUI VCJRVJUJO BOE EFTUSPZFE CZ QSPUFPTPNFT. 2.AVUPQIBHZ PG DFMMVMBS DPNQPOFOUT JOWPMWFT HFOFSBUJPO PG BVUPQIBHJD WBDVPMFT.

### 5IFTF WBDVPMFT GVTF XJUI MZTPTPNFT XIPTF IZESPMZUJD FO[ZNFT CSFBLEPXO DFMMVMBS DPNQPOFOUT.

### IV.**METAP-ASIA**

### A.A DIBOHF JO TUSFTT PO BO PSHBO MFBET UP B DIBOHF JO DFMM UZQF 	NFUBQMBTJB
. 

### 1..PTU DPNNPOMZ JOWPMWFT DIBOHF PG POF UZQF PG TVSGBDF FQJUIFMJVN 	TRVBNPVT

### DPMVNOBS PS VSPUIFMJBM
 UP BOPUIFS 2..FUBQMBTUJD DFMMT BSF CFUUFS BCMF UP IBOEMF UIF OFX TUSFTT. B.BBSSFUU FTPQIBHVT JT B DMBTTJD FYBNQMF.

# **GrowthAdaptations,** **Cellular** 

# **Injury,andCellDeath**

##### **pathoma.compathoma.compathoma.compathoma.com**1

For example: Heart It has a function of pumping against the Systemic BP & it is in homeostasis when it deals with that physiologic stress.

If the organ has to do more work, it will become bigger in order to do the excess work. It may occur via hypertrophy or hyperplasia.

A cell has a skeleton k/a cytoskeleton & it is what gives the cell its size & its shape. If we want the cell to get bigger, we are going to have to increase the production of cytoskeleton & it is primarily made up of proteins.

# **1**1


---

###### Page 2

![Unit1Pathoma_2_10](Generated/images/Unit1Pathoma_2_10.png)

![Unit1Pathoma_2_15](Generated/images/Unit1Pathoma_2_15.png)

### 

  1.ETPQIBHVT JT OPSNBMMZ MJOFE CZ OPOLFSBUJOJ[JOH TRVBNPVT FQJUIFMJVN 	TVJUFE UP

### IBOEMF GSJDUJPO PG B GPPE CPMVT
. 2.ADJE SFGMVY GSPN UIF TUPNBDI DBVTFT NFUBQMBTJB UP OPODJMJBUFE NVDJOQSPEVDJOH

### DPMVNOBS DFMMT 	CFUUFS BCMF UP IBOEMF UIF TUSFTT PG BDJE 'JH. 1.2
. C. .FUBQMBTJB PDDVST WJB SFQSPHSBNNJOH PG TUFN DFMMT XIJDI UIFO QSPEVDF UIF OFX DFMM

### UZQF.

### 1. .FUBQMBTJB JT SFWFSTJCMF JO UIFPSZ XJUI SFNPWBM PG UIF ESJWJOH TUSFTTPS. 2. 'PS FYBNQMF USFBUNFOU PG HBTUSPFTPQIBHFBM SFGMVY NBZ SFWFSTF BBSSFUU

### FTPQIBHVT. D. 6OEFS QFSTJTUFOU TUSFTT NFUBQMBTJB DBO QSPHSFTT UP EZTQMBTJB BOE FWFOUVBMMZ SFTVMU JO

### DBODFS.

### 1. 'PS FYBNQMF BBSSFUU FTPQIBHVT NBZ QSPHSFTT UP BEFOPDBSDJOPNB PG UIF

### FTPQIBHVT. 2. AOPUBCMFFYDFQUJPO JT BQPDSJOF NFUBQMBTJB PGCSFBTUXIJDIDBSSJFTOP JODSFBTFE

### SJTL GPS DBODFS. E.VJUBNJO A EFGJDJFODZ DBO BMTP SFTVMU JO NFUBQMBTJB.

### 1. V J U B N J O A J T O F D F T T B S Z G P S E J G G F S F O U J B U J P O P G T Q F D J B M J [ F E F Q J U I F M J B M T V S G B D F T T V D I

### BT UIF DPOKVODUJWB DPWFSJOH UIF FZF. 2.IO WJUBNJO A EFGJDJFODZUIFUIJO TRVBNPVT MJOJOH PG UIF DPOKVODUJWB VOEFSHPFT

### NFUBQMBTJB JOUP TUSBUJGJFE LFSBUJOJ[JOH TRVBNPVT FQJUIFMJVN. 5IJT DIBOHF JT

### DBMMFE LFSBUPNBMBDJB	'JH.1.
. '. .FTFODIZNBM 	DPOOFDUJWF
 UJTTVFT DBO BMTP VOEFSHP NFUBQMBTJB.

### 1. A DMBTTJD FYBNQMF JT NZPTJUJT PTTJGJDBOT JO XIJDI DPOOFDUJWF UJTTVF XJUIJO NVTDMF

### DIBOHFT UP CPOF EVSJOH IFBMJOH BGUFS USBVNB 	'JH. 1.
.

### V**D:SP-ASIA**

.

### A.DJTPSEFSFEDFMMVMBS HSPXUI

### B..PTU PGUFO SFGFST UP QSPMJGFSBUJPO PG QSFDBODFSPVT DFMMT

### 1.'PS FYBNQMF DFSWJDBM JOUSBFQJUIFMJBM OFPQMBTJB 	CI/
 SFQSFTFOUT EZTQMBTJB BOE JT

### BQSFDVSTPSUPDFSWJDBMDBODFS. C.0GUFO BSJTFT GSPN MPOHTUBOEJOH QBUIPMPHJD IZQFSQMBTJB 	F.H. FOEPNFUSJBM

### IZQFSQMBTJB
 PS NFUBQMBTJB 	F.H. BBSSFUU FTPQIBHVT
D.DZTQMBTJB JT SFWFSTJCMF JO UIFPSZXJUIBMMFWJBUJPO PGJODJUJOHTUSFTT.

### 1.IG TUSFTT QFSTJTUT EZTQMBTJB QSPHSFTTFT UP DBSDJOPNB 	JSSFWFSTJCMF
.

### VI**AP-ASIA AND H:POP-ASIA**

.

### A.AQMBTJB JTGBJMVSF PG DFMMQSPEVDUJPO EVSJOHFNCSZPHFOFTJT	F.H.VOJMBUFSBM SFOBM

### BHFOFTJT
. B.)ZQPQMBTJB JT B EFDSFBTF JO DFMM QSPEVDUJPO EVSJOH FNCSZPHFOFTJT SFTVMUJOH JOB

### SFMBUJWFMZ TNBMM PSHBO 	F.H. TUSFBL PWBSZ JO 5VSOFS TZOESPNF
.

**Fig.** **1.1** Left ventricular hypertrophy. (Courtesy of **Fig.1.2** Barrett esophagus. Aliya Husain, MD) 

### 22**FUNDAMENTALS OF PATHOLOGY**

Apocrine Metaplasia - It is one of the change that is 

seen in association with fibrocystic change in the breast. - The fibrocystic changes can be associated with the future development of breast cancer, however apocrine metaplasia does not increase the risk of cancer.

Plasia means growth, Dys means bad

The term dysplasia is only used for epithelial cells

A means without Hypo means less


---

###### Page 3

![Unit1Pathoma_3_31](Generated/images/Unit1Pathoma_3_31.png)

![Unit1Pathoma_3_41](Generated/images/Unit1Pathoma_3_41.png)


---

###### Page 4

![Unit1Pathoma_4_31](Generated/images/Unit1Pathoma_4_31.png)

![Unit1Pathoma_4_41](Generated/images/Unit1Pathoma_4_41.png)


---

###### Page 5

Vitamin A deficiency

1. The first thing that comes to mind is night blindness 2. Patients who are vitamin A deficient can be deficient in their immune system, because vitamin A is necessary for proper maturation of cells of the immune system. 3. Its deficiency can also lead to metaplasia.

- The conjuctiva is composed of a highly specialized squamous epithelium (transparent) & vitamin A is required to keep it that way, deficiency of vitamin A can lead to thickening of that surface, k/a keratomalacia (White colored layer)

15/17 Translocation leads to Acute Promyelocytic Leukemia - 15/17 translocation involves the Vitamin A receptor (retinoic acid receptor)

![Unit1Pathoma_5_279](Generated/images/Unit1Pathoma_5_279.png)

![Unit1Pathoma_5_289](Generated/images/Unit1Pathoma_5_289.png)

- So, it disrupts the vitamin A receptor & that causes the cells to remain trapped in the blast state & their accumulation then leads to Pro-myelocytic leukemia - One of the treatment of Pro-Myelocytic Leukemia is ATRA which is short for All trans retinoic acid, it is a derivative of vitamin A. This derivative has the ability to bind to the mutated receptor which then allows the cells to mature & become neutrophills.

Metaplasia

metaplastic cells are better able to handle the new stress:

- Repeated gastric acid causes stratified squamous epithelium of lower esophagus to be replaced with columnar epithelium + goblet cells to be able to better handle stress (Barrett' esophagus)

- Repeated cigarette smoke causes respiratory ciliated columnar epithelium to be replaced by stratified squamous epithelium


---

###### Page 6

![Unit1Pathoma_6_31](Generated/images/Unit1Pathoma_6_31.png)

![Unit1Pathoma_6_41](Generated/images/Unit1Pathoma_6_41.png)

Vitamin A Facts 


---

###### Page 7

Mesenchymal Tissues

- Bone, blood vessels, cartilage & fats are mesenchymal in origin (also called connective tissue)

Myositis Ossificans

- In Myositis Ossificans, inflammation of the skeletal muscle results in a metaplastic production of bone in the skeletal muscle, it is usually after a trauma when the skeletal muscle is healing. - This is not be confused with osteosarcoma, which can be ruled out by

![Unit1Pathoma_7_139](Generated/images/Unit1Pathoma_7_139.png)

![Unit1Pathoma_7_149](Generated/images/Unit1Pathoma_7_149.png)

a. The bone adjacent is normal b. Distinct separation between bony metaplasia with the bone

*note it is separated from the bone-its in the muscle (it is not an osteosarcoma)

What musculoskeletal disorder is characterized by metaplasia of skeletal muscle to bone? - Myositis ossificans

- The non-hereditary form (myositis ossificans traumatica) is due to trauma to muscle causing bone to form

- hereditary (myositis ossificans progressiva) is due to an autosomal dominant mutation in the activin type 1 receptor, causing endothelial cells to transform to mesenchymal cells and then to bone


---

###### Page 8

![Unit1Pathoma_8_31](Generated/images/Unit1Pathoma_8_31.png)

![Unit1Pathoma_8_41](Generated/images/Unit1Pathoma_8_41.png)


---

###### Page 9

Atrophy

1. Atrophy via decrease in cell size may occur via autophagy of cellular components

This process is mediated by the Beclin-1 core complex; which helps generate autophagic vacuoles that consume cellular organelles, these combine with lysozymes whose hydrolytic enzymes break down organelles for nutrients

![Unit1Pathoma_9_102](Generated/images/Unit1Pathoma_9_102.png)

![Unit1Pathoma_9_112](Generated/images/Unit1Pathoma_9_112.png)

![Unit1Pathoma_9_135](Generated/images/Unit1Pathoma_9_135.png)

![Unit1Pathoma_9_145](Generated/images/Unit1Pathoma_9_145.png)

Autophagy is a response to a state of cellular starvation, this is recognized by Akt and results in inhibition of mTOR, relieving inhibition of autophagy


---

###### Page 10

![Unit1Pathoma_10_71](Generated/images/Unit1Pathoma_10_71.png)

![Unit1Pathoma_10_81](Generated/images/Unit1Pathoma_10_81.png)

2. Atrophy via decrease in cell size may occur via ubiquitin-proteasome degradation of cytoskeleton - The Proteasome is an intracellular tagging system that allows for degradation of misfolded / unwanted / used up / damaged intermediate filaments of the cytoskeleton are "tagged" with ubiquitin and destroyed by proteasomes


---

###### Page 11

![Unit1Pathoma_11_63](Generated/images/Unit1Pathoma_11_63.png)

![Unit1Pathoma_11_73](Generated/images/Unit1Pathoma_11_73.png)

Atrophy via decrease in cell number occurs via apoptosis - This is an ATP-dependent programmed cell death, responding to the presence of pro-death signals or the lack of survival signals


### Footnotes
